AndersLCarlsonMD
Endocrinology • Saint Louis Park, MNDiabetes, Lipid Metabolism
Assistant Professor, Medicine, University of Minnesota Medical School, Minneapolis
Dr. Carlson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1665 Utica Ave S
Ste 100
Saint Louis Park, MN 55416Phone+1 952-541-2500
Education & Training
University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2010
Hennepin HealthcareResidency, Internal Medicine, 2005 - 2008
University of Minnesota Medical SchoolClass of 2005
Certifications & Licensure
MN State Medical License 2010 - 2025
WI State Medical License 2010 - 2017
VT State Medical License 2008 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase Start of enrollment: 2019 Oct 23
Publications & Presentations
PubMed
- 128 citationsConsensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.Moshe Phillip, Revital Nimri, Richard M Bergenstal, Katharine Barnard-Kelly, Thomas Danne
Endocrine Reviews. 2023-03-04 - 261 citationsThe Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.Roy W. Beck, Richard M. Bergenstal, Peiyao Cheng, Craig Kollman, Anders L. Carlson
Journal of Diabetes Science and Technology. 2019-01-13 - 11 citationsContinuous Glucose Monitoring Integration for Remote Diabetes Management: Virtual Diabetes Care with Case Studies.Anders L. Carlson, Thomas W. Martens, Libby Johnson, Amy Criego
Diabetes Technology & Therapeutics. 2021-09-02
Journal Articles
- Fast‐Acting Insulin Aspart Versus Insulin Aspart in the Setting of Insulin Degludec‐Treated Type 1 Diabetes: Efficacy and Safety from a Randomized Double‐Blind TrialJohn B Buse, Anders L Carlson, Diabetes, Obesity and Metabolism
Press Mentions
Remote Diabetes Management Using CGM and Telemedicine Visits Can Improve Glycemic ControlSeptember 22nd, 2021- Medtronic Touts Trial Results for InPen Smart Insulin Pen, Extended Infusion SystemJune 28th, 2021
- Omnipod 5 ‘Artificial Pancreas’ Shows Benefit in Type 1 DiabetesJune 27th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
